OmanDocSign in

Curriculum · Pediatric / Nutrition & Growth / EPI / Routine Child Examination

Toxic shock syndrome

What it is

Toxic shock syndrome comes in two forms, and an exotoxin is behind both.

The exotoxin gives an erythematous rash, and skin desquamation follows 1-2 weeks after rash. The causes are written as toxin-producing Staphylococcus aureus and group A streptococci.

Where the toxin comes from, and who is at risk

Look for the site where the strain has taken hold:

The risk factors to explore in history are given again in the worked case: use of tampons, presence of nasal packing, skin-soft tissue infections, immunosuppression.

In the nose this is not a side note. Toxic shock syndrome is one of the late complications of nasal packing, beside pressure necrosis, septal hematomas and abscesses, and sinusitis; the immediate complication is neurogenic syncope from traumatic packing. This is why any pack left > 48 hours: give antibiotics. Anterior hemorrhage takes an anterior pack for 2 days, posterior hemorrhage a posterior pack with admission to hospital and packs in for 3-5 days, and merocel or gauze is kept max for 2 days.

How it presents

The manifestation is fever >39 C, hypotension, and a diffuse erythematous, macular rash that will peel later on.

The worked case: an adolescent female treated for epistaxis 2 days ago presents with fever, feeling generally unwell and hypotensive on assessment, with labs of multiorgan failure. The clinical findings are a diffuse, macular erythematous rash, desquamation of palms and soles, and bluish discoloration of digits.

The labs that go with it are the labs of multiorgan failure: Hb 8.1 g/dL, PLT 35,000, WBC 24 and ANC 21; PT 30.5 sec (10-13), aPTT 60 sec (26-36), TT 25 sec (12-16), fibrinogen <0.1 (2-4 g/L); Cr 250 umol/L (60-110), Urea 23 mmol/L (2.5-7.1), HCO3 18 mmol/L (22-26), Na 142 mmol/L (135-145), K 5.1 mmol/L (3.5-5.0); ALT 502 IU/L (5-40), AST 695 IU/L (5-40), Bilirubin 40 umol/L (5-17), ALP 205 IU/L (35-130).